Search the hub
Showing results for tags 'Pharmacist'.
Found 182 results
-
Content Article
This is part of our new series of Patient Safety Spotlight interviews, where we talk to people about their role and what motivates them to make health and social care safer. Roohil talks to us about the vital role of pharmacists in making sure medications help patients, rather than causing harm. She highlights the global threat of substandard and counterfeit medicines, the need to improve access to medicines and the importance of having pharmacists 'on the ground' to help patients understand how to take them. -
Content ArticleAs the global population ages, more people are likely to suffer from multiple long term illnesses and therefore take multiple medications. This report by the World Health Organization highlights the importance of leadership in nurturing a culture that prioritises safe, high-quality prescribing, provides guidance on medication review, and emphasises the role of the patient in prescribing decisions. It also examines the role of multi-professional teams across the healthcare system, including amongst policy makers. The report includes tools and case studies which illustrate a systematic approach that can be followed across the health and care system to ensure that patients are integral to the decisions about their medications.
-
Content Article
Belfast Healthy Cities: Pharmacy Schools Programme (2021)
Patient-Safety-Learning posted an article in Medication
The Pharmacy Schools Programme is an innovative teaching resource developed by Belfast Healthy Cities. Using a health literacy approach, it is designed to be used in primary schools in Northern Ireland to help educate children about self-care, medication safety and community pharmacy services. -
Content ArticleThis article in the British Journal of Clinical Pharmacology aimed to calculate the medication costs of potentially inappropriate prescribing for middle-aged adults compare with the cost of consensus-validated, evidence-based, ‘adequate’ alternative prescribing scenarios. It used a Delphi consensus panel and cross-sectional study to examine primary care data of 55,880 patients aged 45-64 years old in South London. The study found that duplicate drug classes was the most costly criterion for both PIP and alternative prescribing. It identified no substantial cost difference between adequate prescribing versus PIP and the authors recommend that future studies investigate the wider health economic costs of alternative prescribing, such as reducing hospital admissions.
-
Content ArticleUnsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. The World Health Organization (WHO) has launched the Third WHO Global Patient Safety Challenge: Medication Without Harm to improve medication safety. Considering the huge burden of medication-related harm, Medication Safety has also been selected as theme for World Patient Safety Day 2022. WHO has launched a series of webinars to introduce the strategic framework for implementation of the Challenge, technical strategies, tools and provide technical support to countries for reducing medication-related harm. The webinars share country and patient experiences in implementing the Challenge. This webinar focuses on the role of patients and their families in improving medication safety, recognising that they are the only constants in increasingly complex healthcare systems, and that they can provide essential information and feedback.
-
Content ArticleThe Additional Roles Reimbursement Scheme (ARRS) was introduced in England in 2019 as a key part of the government’s manifesto commitment to improve access to general practice. The aim of the scheme is to support the recruitment of 26,000 additional staff into general practice. This is a huge ambition and requires significant and complex change across general practice. While primary care networks (PCNs) have swiftly recruited to these roles, they are not being implemented and integrated into primary care teams in an effective way. This research by The King's Fund focused on four roles to examine the issues related to their implementation: social prescribing link workers first contact physiotherapists paramedics pharmacists. The research examined the experiences of people working in these roles, and of the people managing them. It found a lack of shared understanding about the purpose or potential contribution of the roles, combined with ambiguity about what multidisciplinary working would mean for GPs. If the scheme is to be successfully implemented, it will require extensive cultural, organisational and leadership development skills that are not easily accessible to PCNs.
-
Content ArticleThis report by the Care Quality Commission (CQC) looks at medication safety in NHS trusts, focusing on the role of medication safety officers.
-
Content ArticleDaily safety briefings, also referred to as “huddles,” are conducted within hospitals in efforts to minimize errors and improve patient safety. These briefings are intended to be quick, efficient, and meaningful to health care workers. The purpose of this research is to assess current and perceived best practices related to safety huddles in health-system pharmacy departments, including timing, location, persons involved, and topics covered.
-
Content ArticleSoojin Jun, a pharmacist and a patient advocate, discusses three ways in which pharmacists can help solve the health crisis in the US."The first and foremost value of recognizing pharmacists as providers is that we can help deprescribing medications and guide patients to healthier lives for many chronic illnesses. Many insurance and government sponsored programs are wasting money by “restricting” how pharmacists should practice under their laws and regulations when they can better use the time and money by “guiding” how pharmacists could practice as providers."
-
Content ArticleClinical pharmacists reduce medication errors and optimise the use of medication in critically ill patients, although actual staffing level and deployment of UK pharmacists is unknown. The primary aim of this study was to investigate the UK deployment of the clinical pharmacy workforce in critical care and compare this with published standards. The authors conclude that investment in pharmacy services is required to improve access to clinical pharmacy expertise at weekends, on MDT ward rounds and for other critical care activities.
-
Content ArticleThis Clinical Audit Guide has been written to help community and hospital pharmacists prepare for and conduct clinical audits. To view this guidance you need to be a Royal Pharmaceutical Society member.
-
Content Article
NHS England: Support for prescribers
Patient Safety Learning posted an article in Medication administration
NHS England has commissioned the Specialist Pharmacy Service to provide prescribers with all the support they need to: Stop prescribing medicines which are not clinically-effective or cost-effective Provide clear information to patients to help them make meaningful choices and decisions about their treatment Help people to get the benefits they want from their prescribed medicines Encourage people to ‘self-care’ and choose not to take a medicine if they don’t really need one Take positive action to reduce waste so we stop throwing away so many medicines. -
Content ArticleDr Helen Simpson, Lisa Shepherd and Dr Steve Kell summarise the guidance and implementation of the steroid emergency card in primary care.
-
Content ArticleThis research focused on the Clinical pharmacist (CP) interventions from the PROTECTED-UK cohort. Data was collected from 21 adult critical care units over 14 days and interventions were catergorised as an error, optimisation or consults, with pharmacy service demographics also being collected by investigator survey.
-
Content ArticleThe present research conducted a prospective observational study in 21 UK critical care units (CCU's) from 5-18 November 2012 with the aim to describe clinical pharmacist interventions. Data was collected via a web portal where specialist critical care pharmacists could make their reports, with each intervention classified as medication error, optimization or consult. A total of 20, 517 prescriptions were reviewed with 3294 interventions recorded during the weekdays. Results demonstrated that both medication error resolution and pharmacist-led optimisation rates were substantial.
-
Content ArticleThe Patient Safety Authority are inviting PharmD students and faculty to submit their manuscripts by 30 June. A panel of guest editors—pharmacy experts from across the United States—will select their favourites.
-
Content ArticleThis qualitative study in Research in Social and Administrative Pharmacy examined how staff working in UK community pharmacy during the first waves of the Covid-19 pandemic in 2020 responded and adapted to new pressures on their services to maintain patient safety. From responses gathered from 23 community pharmacy staff in England and Scotland, the authors identified five themes: Covid-19, an impending threat to system Patient safety stressors during the first waves of Covid-19 Altering the system, responding to system stressors Monitoring and adjusting Learning for the future. They found that pharmacy staff responded and adapted to the evolving situation, monitoring the success of measures and protocols adopted in response to the pressures of the pandemic.
-
Content ArticleIn North America, although pharmacists are obligated to ensure prescribed medications are appropriate, information about a patient’s reason for use is not a required component of a legal prescription. The benefits of prescribers including the reason for use on prescriptions is evident in the current literature. However, it is not standard practice to share this information with pharmacists.The aim of this study was to characterise the research on how including the reason for use on a prescription impacts pharmacists.The results suggest that including the reason for use on a prescription can help the pharmacist catch more errors, reduce the need to contact prescribers, support patient counseling, impact communication, and improve patient safety. Reasons that may prevent prescribers from adding the reason for use information are concerns about workflow and patient privacy.
-
Content ArticleThis white paper documents a roundtable discussion held at the International Forum on Quality and Safety in Health Care in Europe 2021. Participants discussed how smart medication management can be improved to optimise healthcare quality and efficiency. The meeting was chaired by Yu-Chuan (Jack) Li, a researcher of artificial intelligence (AI) in medicine and medical informatics, and editor-in-chief of BMJ Health and Care Informatics.
-
Content Article
Blog - Safe medicine saves lives (14 January 2022)
Patient-Safety-Learning posted an article in Medication
In this blog, Roohil Yusuf, Global Pharmacy Advisor at Save the Children, looks at the different factors involved in providing access to life-saving medication, including planning, sourcing, use and management of medicines. She tells the story of Habibah, a three-year-old girl from Nigeria, who was able to access medication for Severe Acute Nutrition and tuberculosis at one of Save the Children's treatment centres. She also looks at the dangers of counterfeit and expired medicines, and explores how organisations can take steps to prevent poor quality, counterfeit or expired medicines being given to patients. -
Content ArticleThis scoping review in JMIR Human Factors looked at existing research into how including the reason for use on a prescription impacts pharmacists. It suggests that including the reason for use on a prescription can help the pharmacist catch more errors, reduce the need to contact prescribers, support patient counselling, impact communication and improve patient safety. Concerns about workflow and patient privacy may be factors that prevent the inclusion of use information. The review identified that more research is needed to better understand how the inclusion of use information affects pharmacists.
- Posted
- 1 comment
-
1
-
- (and 3 more)
-
EventuntilThis Westminster Health Forum conference will focus on next steps for pharmacy services in healthcare delivery, and opportunities to develop the role of community pharmacy as part of the health service in England. It comes amidst proposals to increase prescribing powers for pharmacists and reform training to enable pharmacists to work as independent prescribers immediately following graduation, as well as the Health Secretary announcing additional pharmacy services within the Primary Care Recovery Plan, and also indicating that implementation of a Pharmacy First system in England is being considered. The conference takes place against the backdrop of an evolving healthcare landscape, including developments in integrated care systems and digital transformation, an expected update to the NHS Long Term Plan, and wider strategic initiatives to implement alternatives to medicine, such as the Overprescribing Review. We expect discussion on opportunities to develop pharmacy services as a key component of future NHS and community care delivery. It will include keynote sessions with Gisela Abbam, Chair, General Pharmaceutical Council; Andrew Lane, Chair, National Pharmacy Association; Matthew Armstrong, Senior Manager, Pharmacy Contracts and Project Developments, Walgreens Boots Alliance; and a senior speaker confirmed from the Professional Record Standards Body. Overall, areas for discussion include: strategic ambitions: the opportunity for a Pharmacy First scheme in England - long-term aims for pharmacy services in the context of an updated NHS Long Term Plan. community pharmacy: future role in improvements to key service areas such as general practice, primary care and the ambulance service - delivering medicine optimisation in community care. the workforce: priorities for upskilling - improving training to increase the number of independent prescribers and develop the services that pharmacists can offer. digital pharmacy: key areas for expansion - supporting efficiency in prescription management - potential for digital services to allow patients more control over their care. further development areas: social prescribing services and non-medical treatments - the NHS STOMP programme - structured medicine reviews to support reduction of overprescribing. Register
-
Event
SMASH GM Dashboard – Launch event webinar
Patient Safety Learning posted an event in Community Calendar
untilThe new and re-developed SMASH Dashboard is now ready for rollout across Greater Manchester. The Safety Medication Dashboard (SMASH) has been developed and tested by GM PSTRC researchers. It builds on the same prescribing indicators as PINCER and is a pharmacist-led intervention using audit and feedback. In this 1-hour webinar, we will showcase the new dashboard which utilises the GMCR BI Analytics Platform and provide an overview on how it works, and how it differs from the current platform. We will share the journey the SMASH has been on to this point, and the benefits it will now bring to the GM system. Details will also be provided on how to access and set up accounts, and the local processes to follow. We will have guest speakers on the day from across all of the SMASH journey and an opportunity, if time, to answer some questions. Agenda Outline: Introduction The SMASH Journey The New Dashboard and Tutorial Benefits of the New Platform Access and Processes for Your Locality Q & A Register -
EventuntilPharmacy Forum NI and the DoH Strategic Planning & Performance Group (SPPG) have created a three-part webinar series entitled, ‘A systematic Approach to Insulin Safety in Community Pharmacy’. The first webinar in the series will take place on Wednesday 21 September 2022 at 7-9pm via Zoom and will focus on an introduction to human factors, concepts & tools, and their relevance to patient/medication safety and the wellbeing of the pharmacy team. Event programme and registration Who should attend? These events are targeted at all members of the community pharmacy team who play a part in the safe supply of medicines to patients, namely: pharmacists and foundation trainee pharmacists pharmacy technicians and assistants owners and superintendents medicines safety leads Guest speakers We are delighted to partner with Professor Paul Bowie and Dr Helen Vosper for the three-part event series. Professor Paul Bowie is a Safety Scientist, Medical Educator and Chartered Ergonomist and Human Factors specialist. He has over 25 years’ experience in a range of quality and safety leadership and advisory roles in healthcare, medical defence, military medicine and academia. He gained his doctorate in significant event analysis from the University of Glasgow in 2004 and has published over 150 papers on healthcare quality and safety in international peer-reviewed journals and co-edited a book on safety and improvement. Paul is also Honorary Professor and a PhD supervisor/examiner in the Institute of Health and Wellbeing at the University of Glasgow and a Visiting Professor at Queen’s University, Kingston, Canada. He is Honorary Fellow of the Royal College of Physicians of Edinburgh and the Royal College of General Practitioners, and a Chartered Member of the UK Institute of Ergonomics and Human Factors where he is the patient safety lead of the healthcare specialist interest group Dr Helen Vosper is a chartered ergonomist and graduate of the Loughborough Human Factors Masters Programme and an academic with 15 years’ experience of teaching Human Factors to healthcare students and professionals, including pharmacy students and pharmacists. She is currently the lead for Patient Safety in the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen. Helen also has a part-time role as a Senior Investigation Science Educator at the Healthcare Safety Investigation Branch and is a scientific adviser in Human Factors and Patient Safety to NHS Education for Scotland.
-
EventuntilThe International Alliance of Patients’ Organizations (IAPO) and Patient Academy for Innovation and Research (PAIR Academy) in partnership with Dakshama Health are launching a series of webinars to introduce the Strategic Framework of the Global Patient Safety Challenge - Medication Without Harm. The theme of the 6th webinar of the medication without harm webinar series is "Medication Safety in Polypharmacy and Transitions of Care”. Register for the webinar The patient safety series of webinars will focus on the strategic framework of the Global Patient Safety Challenge, which depicts the four domains of the challenge: patients and the public, health care professionals, medicine, and systems and practices of medication, and the three key action areas—namely polypharmacy, high-risk situations, and transitions of care, The series of webinars will share challenges, technical strategies, tools, and patient experiences in implementing the Strategic Framework of the Global Patient Safety Challenge to reduce medication-related harm.
